CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells

A transmembrane protein CD133 has been implicated as a marker of stem-like glioma cells and predictor for therapeutic response in malignant brain tumours. CD133 expression is commonly evaluated by using antibodies specific for the AC133 epitope located in one of the extracellular domains of membrane...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrantes-Freer, Alonso, Renovanz, Mirjam, Eich, Marcus, Braukmann, Alina, Sprang, Bettina, Spirin, Pavel, Pardo, Luis A., Giese, Alf, Kim, Ella L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472699/
https://www.ncbi.nlm.nih.gov/pubmed/26086074
http://dx.doi.org/10.1371/journal.pone.0130519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472699/
https://www.ncbi.nlm.nih.gov/pubmed/26086074
http://dx.doi.org/10.1371/journal.pone.0130519

Ejemplares similares